DV
Dividend Vision

CRBP — Corbus Pharmaceuticals Holding

Corbus Pharmaceuticals Holding (CRBP)

Total return is -88.8% over the past 11.8 years, 470.6 points behind SPY at 381.8%. Its deepest 1-year drawdown was 61.9%.

CRBP is a single-stock equity holding in Corbus Pharmaceuticals, a biopharmaceutical company. As a stock rather than a diversified ETF, it does not have a defined dividend distribution rate, expense ratio, or fund-level characteristics typical of traditional ETFs. This holding appeals primarily to investors seeking direct exposure to a specific pharmaceutical company rather than those pursuing broad dividend income or diversified equity strategies.

CRBP key facts

Asset type
Stock
Asset class
Equity
Inception date
10/27/2014
Last close
$10.09
Market cap
$166,935,440
Average volume
425922.0
Beta
2.556
Payout ratio
0.0
Forward P/E
0.0
EPS
$-5.74